Lack Of Incentives Threatens AMR Investment
Over A Third Of AMRIA Members Have Said They Could Cut AMR Spending
Executive Summary
The AMR Industry Alliance’s 2021 progress report has found that the life sciences industry is helping to shape a positive future outlook in the fight against antimicrobial resistance despite supply-chain disruptions for generics firms, but continued cross-sector collaborations along with policy and regulatory changes toward a more sustainable marketplace are needed.